Natural Killer Cell Therapy Market Is Going to Boom| Novartis, Gilead Sciences, Bristol Myers Squibb

AI Briefing

• – Novartis and Gilead Sciences lead in NK cell therapy development
• – Bristol Myers Squibb's nintedanib gets FDA approval for NK cell therapy
• – Increasing adoption of immunotherapy drives growth in NK cell therapy market